Clinical Trials | September 18, 2025
AstraZeneca's Saphnelo succeeds in Phase III as self-injectable lupus treatment
The TULIP-SC trial investigated the efficacy and safety of subcutaneous Saphnelo
The TULIP-SC trial investigated the efficacy and safety of subcutaneous Saphnelo
Raludotatug deruxtecan is a specifically engineered, potential first-in-class CDH6-directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo
Launches National IVD validation portal and protocols; highlights India’s strengthening health research ecosystem
The study further confirmed that GAL-101 effectively crosses the blood-brain barrier
This approval follows the CDE’s clearance in July of this year for Phase 2/3 clinical studies of CB03-154 in amyotrophic lateral sclerosis
Targeting a 10% reduction in energy and water consumption, and a 30% cut in carbon emissions across facilities by 2025
Bain Capital and Cinven will each retain a minority stake, reflecting their ongoing confidence in STADA’s future growth
Under the terms of this agreement, Synthon will be responsible for obtaining final regulatory approval for its Ozanimod Capsules product
Edwards’ latest-generation balloon-expandable transcatheter heart valve incorporates a proprietary calcification-resistant tissue technology
These orders are from international government tenders in South Africa, Tanzania, and Kenya, as well as from international agencies WHO/UNFPA, NGOs like MSI and PSI
Subscribe To Our Newsletter & Stay Updated
